About
About BTC Health Limited
BTC Health Limited is a Pooled Development Fund managed by LHC Capital Partners Pty Ltd specializing in seed/startup, early venture, mid venture, late venture, emerging growth and growth capital investments. It makes investments in the healthcare, acute pain management, neuro-spinal, cardiovascular, pharmaceutical, medical technologies, biotechnology sector with a focus on post-genomics, stem cell biology, convergence, silicon biology, and nanomedicine. Within post-genomics, it invests in functional genomics, transcriptomics, proteomics, structural genomics, glycomics, and pharmacogenomics. In the stem cell biology sector, the fund focuses on stem cell therapies. Within convergent technologies, it invests in biomaterials, bionics, biosensors, tissue engineering, microfluidics, and moletronics. In the silicon biology sector, the fund focuses on structure-based drug design, virtual screening, computational library design, and in silico ADME/tox. It invests in companies based in Australia & New Zealand. The fund invests in both listed and unlisted companies.
Visit company website
5 years, 6 months ago
BTC Health Limited is currently in a long term downtrend where the price is trading 3.6% below its 200 day moving average.
From a valuation standpoint, the stock is 21.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 202.8.
BTC Health Limited's total revenue sank by 78.1% to $19K since the same quarter in the previous year.
Its net income has increased by 19.1% to $-179K since the same quarter in the previous year.
Finally, its free cash flow fell by 70.8% to $-106K since the same quarter in the previous year.
Based on the above factors, BTC Health Limited gets an overall score of 2/5.